Input interpretation
![fluoxetine | 2, 3, 5-trifluorophenol](../image_source/f6a97a59030b374f98f4cf5c23d10a27.png)
fluoxetine | 2, 3, 5-trifluorophenol
Chemical names and formulas
![| fluoxetine | 2, 3, 5-trifluorophenol formula | C_17H_18F_3NO | F_3C_6H_2OH Hill formula | C_17H_18F_3NO | C_6H_3F_3O name | fluoxetine | 2, 3, 5-trifluorophenol IUPAC name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | 2, 3, 5-trifluorophenol alternate names | deprex | fluval | prozac | (none) mass fractions | C (carbon) 66% | F (fluorine) 18.4% | H (hydrogen) 5.87% | N (nitrogen) 4.53% | O (oxygen) 5.17% | C (carbon) 48.7% | F (fluorine) 38.5% | H (hydrogen) 2.04% | O (oxygen) 10.8%](../image_source/23f9edeb9ba6b4ca706edde8b3f3c9b4.png)
| fluoxetine | 2, 3, 5-trifluorophenol formula | C_17H_18F_3NO | F_3C_6H_2OH Hill formula | C_17H_18F_3NO | C_6H_3F_3O name | fluoxetine | 2, 3, 5-trifluorophenol IUPAC name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | 2, 3, 5-trifluorophenol alternate names | deprex | fluval | prozac | (none) mass fractions | C (carbon) 66% | F (fluorine) 18.4% | H (hydrogen) 5.87% | N (nitrogen) 4.53% | O (oxygen) 5.17% | C (carbon) 48.7% | F (fluorine) 38.5% | H (hydrogen) 2.04% | O (oxygen) 10.8%
Structure diagrams
![| fluoxetine | 2, 3, 5-trifluorophenol vertex count | 22 | 10 edge count | 24 | 11 Schultz index | 4718 | 456 Wiener index | 1148 | 110 Hosoya index | 28544 | 82 Balaban index | 1.822 | 2.487](../image_source/7ded1629a2b77da6a6f69fb14eeed1e0.png)
| fluoxetine | 2, 3, 5-trifluorophenol vertex count | 22 | 10 edge count | 24 | 11 Schultz index | 4718 | 456 Wiener index | 1148 | 110 Hosoya index | 28544 | 82 Balaban index | 1.822 | 2.487
3D structure
![3D structure](../image_source/ba720dacce98787c16348639de3685f5.png)
3D structure
Basic properties
![| fluoxetine | 2, 3, 5-trifluorophenol molar mass | 309.33 g/mol | 148.08 g/mol phase | solid (at STP) | solid (at STP) melting point | 158 °C | 29 °C boiling point | | 57 °C density | | 1.457 g/cm^3 solubility in water | insoluble |](../image_source/236bd53d53dd7a055652a4ee4f7ce88b.png)
| fluoxetine | 2, 3, 5-trifluorophenol molar mass | 309.33 g/mol | 148.08 g/mol phase | solid (at STP) | solid (at STP) melting point | 158 °C | 29 °C boiling point | | 57 °C density | | 1.457 g/cm^3 solubility in water | insoluble |
Units
Hydrophobicity and permeability properties
![| fluoxetine experimental LogP hydrophobicity | 4.6 predicted LogP hydrophobicity | 4.1 predicted LogS | -5.26](../image_source/3570cb97df837079aa1126e5007d44f4.png)
| fluoxetine experimental LogP hydrophobicity | 4.6 predicted LogP hydrophobicity | 4.1 predicted LogS | -5.26
Drug interactions
![fluoxetine | acenocoumarol | almotriptan | amitriptyline | amoxapine | amphetamine | anisindione | astemizole | atomoxetine | benzphetamine | carbamazepine | carvedilol | cilostazol | clarithromycin | clomipramine | clozapine | cyclosporin A | cyproheptadine | desipramine | dexfenfluramine | dextroamphetamine | ... (total: 71)](../image_source/2fceab14bedab8b3c3dc4399c5f06c2c.png)
fluoxetine | acenocoumarol | almotriptan | amitriptyline | amoxapine | amphetamine | anisindione | astemizole | atomoxetine | benzphetamine | carbamazepine | carvedilol | cilostazol | clarithromycin | clomipramine | clozapine | cyclosporin A | cyproheptadine | desipramine | dexfenfluramine | dextroamphetamine | ... (total: 71)
Pharmacodynamics and pharmacokinetics
![| fluoxetine absorption | 72% protein binding | 94.5% biological half-life | 48 h lethal dosage LD_50 | 284 mg/kg biotransformation | hepatic](../image_source/b4bf2e3f666ea845046a4201d2c7ba22.png)
| fluoxetine absorption | 72% protein binding | 94.5% biological half-life | 48 h lethal dosage LD_50 | 284 mg/kg biotransformation | hepatic
Units